Case Western, ICBM Medical partner to develop patient screening technology

Case Western Reserve University and Cleveland-based ICBM Medical signed a license agreement to further develop technology to provide patient screening and monitoring for a range of critical clinical conditions including prostate cancer and concussions.

Licensing for the low-cost, rapid screening and monitoring was issued through Case Western’s Technology Transfer Office. Last fall, the two signed a one-year option-to-license agreement for the technology, according to a news release. The next steps will be optimizing designs, producing prototypes and beginning clinical testing in 2018. ICBM Medical so far has received “sufficient funding” to carry it through these steps as it moves toward securing a Series A preferred investment, according to the news release.

“The completion of the CWRU-ICBM Medical license agreement enables us to confidently ramp up the near-term product development activities,” ICBM Medical CEO Stephanie Harrington said in a statement.